<DOC>
	<DOCNO>NCT01270984</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerance compare pharmacokinetic characteristic Luckyvec 400mg tablet ( x 1T ) Glivec 100mg ( x 4T ) administer single-dose healthy volunteer .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetic Characteristics Luckyvec 400mg Tablet , Healthy Subjects</brief_title>
	<detailed_description>Healthy volunteer administrate single-dose period I II ( Crossover ) Luckyvec 400mg tablet ( x 1T ) Glivec 100mg ( x 4T ) Imatinib 400mg . Every time medication , PK parameter safety Luckyvec 400mg tablet Glivec 100mg perform use blood sample conduct test ( Laboratory test , V/S , Physical Examination , etc ) respectively .</detailed_description>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Between 20 age 45 age healthy male BMI : 18~29.9 kg/m2 , ( BMI = ( 체중 [ kg ] ) / ( height [ ] ) 2 ) Agreement write informed consent Clinically significant cardiovascular system , pulmonary system , liver system , renal system , blood system , gastrointestinal system , immune system , skin system , nervous system mental disease ( Past history present ) Subject symptom acute disease within 28 day start administration investigational drug Subject know history affect ADME drug Clinically significant active chronic disease Inadequate result laboratory test AST/ALT &gt; 1.5 x UNL Total bilirubin &gt; 1.5 x UNL Positive reaction HBs Ag , antiHCV Ab , antiHIV Ab , VDRL test Taking ETC ( ethical counter ) medicine within 14 day Taking OTC ( Over counter ) medicine include oriental medicine within 7 day Clinically significant allergic disease ( Except mild allergic rhinitis dermatits seem need medication ) Subject know hypersensitivity reaction imatinib analog Not able take institutional standard meal Previously make whole blood donation within 60 day component blood donation within 20 day Previously blood transfusion within 30 day Previously participate trial within 30 day Continued take caffeine ( caffeine &gt; 5 cup/day ) , drink ( alcohol &gt; 30 g/day ) severe heavy smoker ( cigarette &gt; 1/2 pack per day ) An impossible one participate clinical trial investigator 's decision include reason laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Imatinib mesylate</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>